Drug
Risperdal
Risperdal is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
1
25%
Ph phase_4
1
25%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(2)
Detailed Status
Completed2
Terminated1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
terminated125%
completed250%
withdrawn125%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
NCT04639960
completedphase_4
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
NCT00056498
completedphase_3
Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
NCT00399698
withdrawnphase_2
Metabolic Effects of Antipsychotic Substitution in Children
NCT00910780
Clinical Trials (4)
Showing 4 of 4 trials
NCT04639960Not Applicable
Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion Syndrome
NCT00056498Phase 4
Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
NCT00399698Phase 3
Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.
NCT00910780Phase 2
Metabolic Effects of Antipsychotic Substitution in Children
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4